While attending several recent medical conferences, we learned about some interesting procedure clinical trials that may be of interest to the afib patient community. To learn more, check out the following studies: The nContact CONVERGE Trial Will Study the Convergent Procedure for Treatment of Persistent Atrial Fibrillation The reMARQable Trial Will Study the nMARQ Multielectrode …
Read More
The US FDA has just announced that on September 8, 2011, the FDA Cardiovascular and Renal Drugs Advisory Committee will meet to review whether to recommend approval of rivaroxaban (brand name Xarelto), an alternative to warfarin, for stroke prevention in atrial fibrillation. In this recent video interview, Dr. Elaine Hylek, a leading anticoagulant authority, discussed …
Read More
There is a lot of big news coming out of the European Society of Cardiology (ESC) going on in Barcelona right now. Judging by attendance, this is probably the biggest cardiology event in the world. The big announcement for atrial fibrillation sufferers is the progress towards a replacement for Coumadin (warfarin) coming out of the …
Read More